Predicted^* value of age at school entry (in years), by level of height-for-age. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* value of age at school entry by height-for-age z-score and child’s sex. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* value of age at school entry by height-for-age z-score and mother’s education. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* value of age at school entry by height-for-age z-score and place of residence. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* value of age at school entry by height-for-age z-score and household socioeconomic status. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Change^a in years of age at school entry according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* incidence of repetition by level of height-for-age. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Predicted^* incidence of dropout by level of height-for-age. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Change^a in age at school entry [95% confidence interval]. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Factors associated with AL score (multivariable regression analyses for the third follow-up). by Eric Priedemann (21175492)

Subjects:

Age at school entry, incidence of grade repetition, incidence of dropout, and baseline characteristics of participants. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Change^a in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Change^a in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Subjects: “…demographic surveillance system…”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”